Filing search / Context Therapeutics Inc. / "Oversee"

Search information

Context Therapeutics Inc.

Companies

"Oversee"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

20 results

Newest first Best match first

DEF 14A

CNTX Context Therapeutics Inc.

Definitive proxy

(a)(58)(A) of the Exchange Act to oversee our corporate accounting and financial reporting processes and audits of our financial statements … tax deductibility; oversee all our material employee benefit plans and programs, including the authority to adopt, amend and terminate such plans

26 Apr 24

4:10pm

10-K

2023 FY

CNTX Context Therapeutics Inc.

Annual report

as the “Physician Payments Sunshine Act;” a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical

21 Mar 24

7:36am

DEF 14A

CNTX Context Therapeutics Inc.

Definitive proxy

by the Board in accordance with Section 3(a)(58)(A) of the Exchange Act to oversee our corporate accounting and financial reporting processes … to, where determined appropriate, preserve tax deductibility; oversee all our material employee benefit plans and programs, including the authority

6 Apr 23

4:02pm

424B3

CNTX Context Therapeutics Inc.

12 Apr 22

Prospectus supplement

4:14pm

Act;” a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research

POS AM

CNTX Context Therapeutics Inc.

4 Apr 22

Prospectus update (post-effective amendment)

5:08pm

Payments Sunshine Act;” a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical

Prospectus supplement with pricing info

10 Dec 21

4:46pm

424B4

8oibbgnsu60v ferqi

20 Oct 21

Prospectus supplement with pricing info

5:05pm

S-1/A

mgm29l7q zw700qdcb

IPO registration (amended)

18 Oct 21

12:00am

S-1/A

ez7n2iorov64qqanc

IPO registration (amended)

29 Sep 21

8:24am

S-1/A

6p9znm8o s5o

IPO registration (amended)

24 Sep 21

4:15pm

S-1/A

EX-10.5

acx7f2dvek76khen4py

IPO registration (amended)

10 Sep 21

9:24pm

S-1/A

txmsn7

IPO registration (amended)

10 Sep 21

9:24pm

S-1/A

cfvjnuiinx81ui

IPO registration (amended)

23 Jul 21

4:35pm

S-1/A

ozdxto5f1k 2y

IPO registration (amended)

2 Jul 21

12:00am

Draft registration statement (amended)

12:00am

Filing search / Context Therapeutics Inc. / "Oversee"

20 results

Top filers

Top filing types

Recent filing years